A carregar...

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

BACKGROUND: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia. METHODS: I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Iran J Med Sci
Main Authors: Samadi, Roya, Soluti, Susan, Daneshmand, Reza, Assari, Shervin, Manteghi, Ali Akhoundpour
Formato: Artigo
Idioma:Inglês
Publicado em: Iranian Journal of Medical Sciences 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337760/
https://ncbi.nlm.nih.gov/pubmed/28293046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!